Stories

Updates: Lilly's Global COVID-19 Response

View Story

Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization

View Story

When the World Called for Help with COVID-19, We Were Ready

View Story

Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody

View Story

CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access

View Story

Increasing Diversity in Clinical Trials

View Story

Overcoming Barriers to Biomarker Testing in Cancer

View Story

What Does It Take to Manufacture Neutralizing Antibodies?

View Story

The Power of Loxo Oncology at Lilly

View Story

Lilly Creates Mobile Research Units to Reach Elderly Patients

View Story